Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Response to speculation
This item is over 2 years old; some content may no longer be current
+Undoctored
Response to speculation
Wednesday 29 September 2021, 04:39 PM
Green Cross Health refers to speculation in the Australian media about its participation in a process to acquire Tamaki Health. Green Cross Health advises that it is working with Pacific Equity Partners (PEP) in that process, as the media speculates. The process is in its early stages.
The nature and terms of any transaction for the acquisition of Tamaki Health have yet to be determined. There is no certainty that Green Cross Health will be the successful party or that any transaction will be concluded.
Green Cross Health confirms it is in compliance with its continuous disclosure obligations.